Pemetrexed Dipotassium 100 mg, 500 mg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 100 mg, 500 mg

Reference Brands: Alimta (USA), Pemfexy (USA)

Category: Oncology Cancer Care

Pemetrexed Dipotassium is a Oncology Cancer Care product available as Injection in strengths 100 mg, 500 mg. It corresponds to the reference brands Alimta (USA), Pemfexy (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Pemetrexed dipotassium, marketed under brand names such as Alimta, is a chemotherapy medication used for the treatment of malignant pleural mesothelioma and non-small cell lung cancer (NSCLC). It is particularly indicated for the treatment of unresectable pleural mesothelioma, often in combination with cisplatin, for patients who are not candidates for curative surgery. Pemetrexed interferes with folate-dependent metabolic processes, inhibiting the synthesis of DNA, RNA, and proteins in rapidly dividing cancer cells, thereby slowing tumor growth and inducing cell death. In non-small cell lung cancer, Pemetrexed is approved as a first-line therapy in combination with cisplatin for locally advanced or metastatic disease, as well as for maintenance therapy in patients showing response to initial treatment. Its targeted action against rapidly proliferating cells makes it an effective option in oncology, providing a clinically established approach for managing these aggressive cancers. Pemetrexed is administered intravenously under professional supervision and can be used alone or in combination with other chemotherapeutic agents to enhance therapeutic efficacy. Its widespread use and proven effectiveness have made it a cornerstone in the management of pleural mesothelioma and non-squamous NSCLC.